Hostname: page-component-669899f699-7tmb6 Total loading time: 0 Render date: 2025-05-02T23:14:17.964Z Has data issue: false hasContentIssue false
  • English
  • Français

Atrial flow regulator in transposition of the great arteries, ventricular septal defect, and pulmonary stenosis: a case report

Published online by Cambridge University Press:  02 October 2024

Saïd Bichali Open the ORCID record for Saïd Bichali [Opens in a new window] ,
Alexandre Delarue  and
Ali Houeijeh
Saïd Bichali*
Affiliation:
Univ. Lille, CHU Lille, Paediatric Cardiology, Lille, France
Alexandre Delarue
Affiliation:
Univ. Lille, CHU Lille, Paediatric Cardiology, Lille, France
Ali Houeijeh
Affiliation:
Univ. Lille, CHU Lille, Paediatric Cardiology, Lille, France
*
Corresponding author: Saïd Bichali; Email: [email protected]
Get access Rights & Permissions [Opens in a new window]

Abstract

A 5-month-old girl with transposition of the great arteries, ventricular septal defect, and pulmonary stenosis underwent the implantation of a 6-mm M Atrial Flow Regulator (Occlutech) over an 8-French delivery sheath for significant cyanosis and progressive restriction of the atrial septal defect, without adverse event for 6 months. The Atrial Flow Regulator device could improve blood mixing as a bridge to surgery.

Keywords

Percutaneoustranscatheteratrioseptostomyrashkindpaediatricchildren
Type
Brief Report
Information
Cardiology in the Young , Volume 34 , Issue 10 , October 2024 , pp. 2240 - 2243
Check for updates
Copyright
© The Author(s), 2024. Published by Cambridge University Press

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable

References

Hansmann, G, Sabiniewicz, A, Sabiniewicz, R. Atrial flow regulator for postcapillary pulmonary hypertension: first-in-human transcatheter AFR device implantations in RCM. JACC Case Rep 2022; 4: 878–884.CrossRefGoogle ScholarPubMed
Piccinelli, E, Testa, A, Butera, G. Versatility of atrial flow regulator device in congenital heart disease: a case series. Pediatr Cardiol 2023; 45: 1377–1383.CrossRefGoogle ScholarPubMed
Youssef, DE, Averin, K, Richards, S, et al. A North American, single-center experience implanting fenestrated atrial devices and atrial flow regulators into a heterogeneous group of pediatric pulmonary hypertension patients. Front Pediatr 2023; 11: 1073336.CrossRefGoogle ScholarPubMed
Castaldi, B, Cuppini, E, Sirico, D, etal, Feasibility. Safety, and efficacy of the atrial flow regulator in pediatric patients: a single-center experience. J Soc Cardiovasc Angiogr Interv 2023; 2: 101209.Google ScholarPubMed
Aregullin, EO, Samuel, B, Vettukattil, J. Planned reduction in Fontan fenestration size using the atrial flow regulator. Cardiol Young 2021; 31: 1690–1692.CrossRefGoogle ScholarPubMed
Pascall, E, Jones, MI, Savis, A, Rosenthal, E, Qureshi, SA. Transcatheter creation of a pulmonary artery to left atrial fenestration in a failing Fontan circulation using the atrial flow regulator (AFR). Cardiol Young 2021; 31: 1376–1379.CrossRefGoogle Scholar
Bautista-Rodriguez, C, Hascoët, S, Fraisse, A. Feasibility, safety, and efficacy of atrial flow regulator in children under 10 kg. Catheter Cardiovasc Interv 2023; 101: 396–400.CrossRefGoogle Scholar
Butera, G, Piccinelli, E, Kolesnik, A, et al. Implantation of atrial flow regulator devices in patients with congenital heart disease and children with severe pulmonary hypertension or cardiomyopathy—an international multicenter case series. Front Cardiovasc Med 2024; 10: 1332395.CrossRefGoogle ScholarPubMed
An, K, Li, S, Yan, J, Wang, X, Hua, Z. Transposition of the great arteries, ventricular septal defect, and pulmonary stenosis: modified REV versus rastelli. Pediatr Cardiol 2021; 42: 762–767.CrossRefGoogle ScholarPubMed
Cinteza, E, Carminati, M. Balloon atrial septostomy - almost half a century after. Maedica 2013; 8: 280–284.Google ScholarPubMed